DexCom, Inc. Price Today
DexCom, Inc.
DXCM
Healthcare
$46.64B
💰
Market Cap
167.1
💸
Price to Earnings
$0.7
🎉
EPS
+76
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
14 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
DXCM Price Forecast Target
120.3 👉 175.0 +45%
DXCM EPS Forecast
0.7 👉 1.6 +122%
Financials
Profit Margin
11 %
Revenue Growth
25.2 %
Dividend
$ 0
Held Percent
0.4% - Insiders
100.7% - Institutions
-1.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $5.3B
-
💰 Blackrock Inc. $4.0B
-
💰 Baillie Gifford and Company $2.0B
-
💰 State Street Corporation $1.9B
-
💰 Sands Capital Management, LLC $1.7B
Stock Ideas
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…📮FAQ
Some Frequently Asked Questions.
The DexCom, Inc. industry is Medical Devices
The DexCom, Inc. sector is Healthcare
The DexCom, Inc. forecasted predicted Price to Earnings PE ratio is 75.2
The DexCom, Inc. Price to Earnings PE ratio is 167.1
The Market Capitalization of DexCom, Inc. is $46.64B
There are total of 384823124 float shares with 100.7% held by Institutions and 0.4% held by insiders
The MDexCom, Inc. forecasted Earnings per Share EPS is $1.6
The DexCom, Inc. Earnings per Share EPS is 0.7
The DexCom, Inc. company has $1883100000 gross profits with 11 profit margins
The DexCom, Inc. Earnings Growth is 1.227% with 1.277% quarterly earnings growth
The DexCom, Inc. Revenue is $3197600000 with 0.252 revenue growth
The price target for DexCom, Inc. stock is $175.0 for the high target and $131.0 for the low target
The consensus analyst recommendations for DexCom, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for DexCom, Inc. is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 14
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of DexCom, Inc. is 1.1
The dividend of DexCom, Inc. is $0
The dividend yield of DexCom, Inc. is 0%
The biggest institutional and mutual fund holders of DexCom, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Baillie Gifford and Company
- State Street Corporation
The DexCom, Inc. ESG Score is 76, with the following breakdown:
- E: 5.39
- S: 10.24
- G: 8.08